Cystic fibrosis is associated with multiple endocrine complications, which are caused by systemic dysfunction of the cystic fibrosis transmembrane conductance regulator protein. In this Review, Moheet and colleagues describe these conditions, with particular emphasis on the effects of CFTR modulator therapy, as well as the challenges related to ageing in people with cystic fibrosis.
- Amir Moheet
- Kevin J. Scully
- Melissa S. Putman